Phase I Trial of Vorinostat Added to Chemoradiation With Capecitabine in Pancreatic Cancer

Radiotherapy and Oncology - Netherlands
doi 10.1016/j.radonc.2016.04.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

ARCII: A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Combination With Chemoradiation for Locally Advanced Inoperable Pancreatic Cancer

Radiotherapy and Oncology
Nuclear MedicineOncologyRadiologyHematologyImaging
2016English

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Phase I Study of Vorinostat With Gefitinib in BIM Deletion Polymorphism/Egfr Mutation Double‐positive Lung Cancer

Cancer Science
Cancer ResearchMedicineOncology
2020English

Panitumumab Added to Docetaxel, Cisplatin and Fluoropyrimidine in Oesophagogastric Cancer: ATTAX3 Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2016English

A Phase I Trial of Vorinostat and Bortezomib in Children With Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL0916)

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2012English

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2014English

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy